RxDoctor Payments Data

Sarah Fleming

Family · West Palm Beach, FLNPI 1629586102

Payments from drug & device makers

$7,668in general payments, 2019–2025

Across 388 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$958
  • Incyte Corporation$431
  • Sanofi$276
  • AbbVie$270
  • TG Therapeutics, Inc.$250
  • plus $4K from 53 others

What the payments were for

  • Food & beverage$7,668100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson56$1,040
Novartis79$958
Incyte Corporation19$431
Sanofi12$276
AbbVie14$270
TG Therapeutics, Inc.2$250
Takeda Pharmaceuticals U.S.A., Inc.11$245
Genentech USA, Inc.4$228
Amgen12$215
GSK12$214
Daiichi Sankyo Inc.9$210
Merck10$201
AstraZeneca(2 entities)10$189
Jazz Pharmaceuticals Inc.9$139
Tersera Therapeutics LLC5$132
Bayer6$126
Regeneron Healthcare Solutions, Inc.6$120
Pharmacyclics LLC, An Abbvie Company6$118
Ipsen Biopharmaceuticals, Inc5$116
Adaptive Biotechnologies Corporation6$113
Legend Biotech USA Inc.5$111
Pfizer6$107
Sobi, Inc4$104
Stemline Therapeutics Inc.4$104
Eisai Inc.4$97
Boston Scientific3$95
Bristol Myers Squibb4$87
Aspira Women's Health Inc1$80
Lilly USA, LLC4$73
Astellas Pharma US Inc4$73
Array Biopharma Inc4$71
Servier Pharmaceuticals LLC3$70
Boehringer Ingelheim3$69
Seagen Inc.4$65
Immunogen, Inc.3$64
Pharmacosmos Therapeutics Inc.2$63
Myriad Genetic Laboratories, Inc.4$63
Agios Pharmaceuticals, Inc.3$63
Coherus Oncology, Inc.2$62
Beigene USA, Inc.3$60
Taiho Oncology, Inc.3$52
Deciphera Pharmaceuticals Inc.2$51
G1 Therapeutics, Inc.2$40
Puma Biotechnology, Inc.2$36
Pharmaessentia USA Corporation1$28
Exelixis Inc.1$26
Dova Pharmaceuticals2$25
Iovance Biotherapeutics, Inc.1$25
Genmab U.S., Inc.1$23
Karyopharm Therapeutics Inc.1$22
Blueprint Medicines Corporation1$22
ADC Therapeutics America, Inc.1$22
Delcath Systems1$21
Dendreon Pharmaceuticals LLC1$20
Beone Medicines USA, Inc.1$18
CTI Biopharma Corp.1$17
Global Blood Therapeutics, Inc.1$16
E.r. Squibb & Sons, L.L.C.1$14
Recordati_rare_diseases_inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,668 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$27,222
Medicare patients
27
Services billed
562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in West Palm Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →